Drug recall · August 3, 2022
Lansoprazole Delayed-Release Orally Disintegrating Tablets recall
Why: FAILED DISSOLUTION SPECIFICATIONS
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856179, NDC 43598-561-78
- Lots / codes
Lot T2100515, Exp 01/2023
- Quantity
- 2,639 cartons
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- July 13, 2022 · Voluntary: Firm initiated
- Classified
- July 22, 2022
- Reported
- August 3, 2022
- Ended
- December 6, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lansoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.